Covid-19 and Acute Respiratory Distress Syndrome (ARDS) a Clinical Review
Received Date: Sep 01, 2022 / Published Date: Sep 30, 2022
Abstract
The COVID-19 pandemic is a serious problem of the new era. Acute respiratory distress syndrome (ARDS) and respiratory failure are the major lung diseases in COVID-19 patients. Although a COVID-19 vaccine is now available, there is still an urgent need to find potential treatments to reduce the impact of her COVID-19 on already sick patients. Several experimental drugs have been approved by the FDA, but their efficacy and possible side effects are unknown. An increasing number of studies worldwide investigating potential COVID-19-related therapies may help identify effective ARDS treatments. This review article first provides an overview of the immunopathology of ARDS. He then outlines the management of his COVID-19 patient requiring intensive care unit (ICU), focusing on current treatment strategies being evaluated in clinical trials for patients with COVID-19-induced ARDS.
Citation: Yuan S (2022) Covid-19 and Acute Respiratory Distress Syndrome (ARDS) a Clinical Review . J Respir Med 4: 142. Doi: 10.4172/jrm.1000142
Copyright: © 2022 Yuan S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 786
- [From(publication date): 0-2022 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 599
- PDF downloads: 187
